Joe Rogan Experience #1349 - David Sinclair

Joe Rogan Experience #1349 - David Sinclair

The Joe Rogan ExperienceSep 11, 20192h 19m

Joe Rogan (host), David Sinclair (guest), Narrator, Narrator, Narrator

Epigenetic clocks and measuring biological vs chronological ageMetformin, HGH, DHEA, NMN, resveratrol and NAD-boosting strategiesTradeoffs between performance, exercise, and longevity drugsSenescent “zombie” cells and emerging senolytic therapiesGene therapy, CRISPR, and cellular reprogramming to reverse agingLifestyle interventions: fasting, diet, exercise, heat/cold exposure, sleepEthical and societal implications of radical life extension

In this episode of The Joe Rogan Experience, featuring Joe Rogan and David Sinclair, Joe Rogan Experience #1349 - David Sinclair explores david Sinclair Explains How We Might Slow, Stop, Reverse Aging Harvard longevity researcher David Sinclair joins Joe Rogan to discuss the latest science on why we age and how elements of that process may be slowed or even reversed. They cover drug combinations like metformin, DHEA, and human growth hormone that appear to reduce biological age on the Horvath epigenetic clock, as well as Sinclair’s own regimen of NMN, resveratrol, metformin, and lifestyle interventions. Sinclair explains emerging tools such as epigenetic clocks, senolytic drugs that clear “zombie” cells, and gene therapies that can rejuvenate tissues like the retina in mice. The conversation also weaves in practical issues—exercise, fasting, sleep, diet, alcohol—and broader ethical, medical, and societal questions around extending human healthspan.

David Sinclair Explains How We Might Slow, Stop, Reverse Aging

Harvard longevity researcher David Sinclair joins Joe Rogan to discuss the latest science on why we age and how elements of that process may be slowed or even reversed. They cover drug combinations like metformin, DHEA, and human growth hormone that appear to reduce biological age on the Horvath epigenetic clock, as well as Sinclair’s own regimen of NMN, resveratrol, metformin, and lifestyle interventions. Sinclair explains emerging tools such as epigenetic clocks, senolytic drugs that clear “zombie” cells, and gene therapies that can rejuvenate tissues like the retina in mice. The conversation also weaves in practical issues—exercise, fasting, sleep, diet, alcohol—and broader ethical, medical, and societal questions around extending human healthspan.

Key Takeaways

Biological age can now be quantified and may be reversible.

The Horvath epigenetic clock reads chemical marks on DNA (especially cytosine methylation) to estimate biological age and mortality risk. ...

Get the full analysis with uListen AI

NAD-boosting compounds and sirtuin activators are central to Sinclair’s approach.

Sinclair’s lab links aging to declining NAD and sirtuin activity. ...

Get the full analysis with uListen AI

Metformin may aid longevity but can blunt athletic gains, so timing matters.

Some studies show metformin improves metabolic health and potentially lifespan, but it can dampen exercise-induced mitochondrial adaptations and performance. ...

Get the full analysis with uListen AI

Clearing senescent “zombie” cells is a promising anti-aging strategy.

Senescent cells accumulate with age and secrete inflammatory factors that damage tissues and promote disease. ...

Get the full analysis with uListen AI

Gene therapies and cellular reprogramming could restore lost function in specific tissues.

Using viral vectors and a subset of Yamanaka factors, Sinclair’s group has rejuvenated old mouse retinas and even regrown damaged optic nerves, restoring vision and resetting epigenetic age. ...

Get the full analysis with uListen AI

Lifestyle still does the heavy lifting: stress the body, then let it recover.

Across the conversation, Sinclair emphasizes intermittent fasting, maintaining leanness, regular strength and aerobic training, heat/cold exposure, minimizing sugar and refined carbs, moderating alcohol, protecting against UV/DNA damage, and prioritizing good sleep as foundational for slowing aging—drugs and tech are add-ons, not replacements.

Get the full analysis with uListen AI

Extending healthspan could free massive resources and experience for society.

Sinclair argues that keeping people functional into older ages (like his very fit 80-year-old father) could save trillions in healthcare and care costs, while preserving wisdom and productivity. ...

Get the full analysis with uListen AI

Notable Quotes

What this study suggests is that it's not just about slowing down aging, but one day we could be 80, but biologically 30.

David Sinclair

We’re right on the cutting edge of human knowledge. We don’t actually know what the best thing is.

David Sinclair

Don't give me the argument that aging is natural, therefore it's acceptable.

David Sinclair

As time goes on, you understand how you're interfacing with the world. You communicate with people better. You know how to get by.

Joe Rogan

There'll be a time when you can't really tell how old somebody is, especially when we figure out how to reprogram the body to be young again.

David Sinclair

Questions Answered in This Episode

If epigenetic clocks can be reset, what ethical lines should we draw around who gets access to rejuvenation therapies and at what ages?

Harvard longevity researcher David Sinclair joins Joe Rogan to discuss the latest science on why we age and how elements of that process may be slowed or even reversed. ...

Get the full analysis with uListen AI

How should athletes and highly active people weigh potential longevity benefits of drugs like metformin against the documented performance tradeoffs?

Get the full analysis with uListen AI

What would a healthcare system optimized for extending healthspan, not just treating late-stage disease, practically look like?

Get the full analysis with uListen AI

How might widespread senolytic and reprogramming therapies change our notions of retirement, career length, and intergenerational equity?

Get the full analysis with uListen AI

Given the pace of gene therapy and CRISPR advances, how do we balance urgent treatment for severe diseases with the long-term risks of editing human biology?

Get the full analysis with uListen AI

Transcript Preview

Joe Rogan

(clears throat) David Sinclair, Lifespan: Why We Age & Why We Don't Have To. I'm so happy there are people like you out there, 'cause I don't wanna age. I'm aging, clearly, but, uh, I'm not interested in it. I don't like it.

David Sinclair

Yeah. Well, I don't know anybody who does, uh, Joe Rogan. Thanks for having me back on.

Joe Rogan

Thanks for coming back. The first one was a, a smash hit, man. People loved it. Uh, all my friends were very excited. But, uh, I had a question for you right off the bat, um, regarding Metformin. There was actually an article, I'm sure you saw it, recently, um, like within the last couple of days, that was going around through all the mainstream papers. It was, uh, talking about how for w- the use of Metformin, uh, DHEA, and w- was there something else as well that was taking two years-

David Sinclair

Human growth hormone.

Joe Rogan

... human growth hormone, taking two years, two biological years off of people's lives in terms of their, their age, which are natural eight, which are actual ... I'm 52, it would make me 50.

David Sinclair

Right. Even 49.5, according to the study.

Joe Rogan

Ooh.

David Sinclair

Yeah.

Joe Rogan

That's what I'm looking for.

David Sinclair

Yeah, that was a-

Joe Rogan

Get back to the fours.

David Sinclair

... that was a good study. Uh, it, you know, it's only nine people, so we have to repeat this. Um-

Joe Rogan

Were they studs? Did you get like nine super athletes or did you get like schmoes that don't exercise?

David Sinclair

Uh, I, as far as I know, these were just, uh, regular-

Joe Rogan

Schmoes?

David Sinclair

... schmoes, yeah.

Joe Rogan

(laughs)

David Sinclair

Which is good news for schmoes like me.

Joe Rogan

Yes. Good news. Yeah. Well, I mean, that's what you want. You don't want like ... Some people just respond better. They're, they have super bodies, you know?

David Sinclair

Well, the gre- great thing about that, uh, study is first of all, I, I was with the first, uh, the main author on that paper, uh, while it came out. I was over in Israel, uh, as part of my journey up the, the great rift of Africa, ended up in Israel. Anyway, the guy there, uh, Steve Horvath is his name, uh, he and I and a couple of other guys are trying to figure out, uh, not just why we age, why we don't have to, but is aging, uh, truly reversible? And that's what this study suggests is that it's not just about slowing down aging, but one day we could be 80, but biologically 30.

Joe Rogan

Now, when we're talking about the biological age, how is that measured? Is this measured by the length of the telomeres? Is this measured by physical performance? Is it measured by a combination of these factors?

David Sinclair

It's none of that.

Joe Rogan

None of that?

David Sinclair

It's something brand new.

Joe Rogan

Ooh.

Install uListen to search the full transcript and get AI-powered insights

Get Full Transcript

Get more from every podcast

AI summaries, searchable transcripts, and fact-checking. Free forever.

Add to Chrome